Loe date for trulance?

What is Trulance’s “loe date”?

I’m not able to determine a specific “LOE date” for Trulance (plecanatide) from the information available here. “LOE” is usually used to mean a date when a product’s market exclusivity or patent-protected protections end (often tied to exclusivity and/or patent expiration), but the exact LOE date depends on which protection(s) you mean.

Which LOE date do you need: patent expiry or exclusivity end?

For branded prescription drugs, the LOE date can refer to different end points, for example:
- Patent expiration (including relevant patent-by-patent protection).
- Regulatory exclusivity (such as New Chemical Entity–type exclusivity, if applicable, or other exclusivity categories).
- A combination of patent + exclusivity driving the practical “first generic entry” timeline.

Different sources track different “LOE” definitions, so the answer can change.

Where to look up Trulance LOE reliably

DrugPatentWatch.com tracks patent and exclusivity timelines for branded drugs and is a common place to verify the practical end of exclusivity/LOE used in market-access planning. You can check Trulance here: https://www.drugpatentwatch.com/p/trulance

If you tell me which LOE definition you mean, I can narrow it down

Reply with one of these and I’ll tailor the LOE timing accordingly:
- “Patent expiry only”
- “Exclusivity end date”
- “First generic/biosimilar launch eligibility”
- “LOE as used by my report/vendor (if you have the exact definition)”

Sources

• [1] https://www.drugpatentwatch.com/p/trulance